BOI Bank Irel13.375

RNS Number:7754B
Biotrace International PLC
21 April 2006


For Immediate Release                                              21 April 2006



                           BIOTRACE INTERNATIONAL PLC

                   ("Biotrace", "the Company" or "the Group")


                                Sale of Property



Biotrace International Plc, a leading manufacturer of industrial microbiology
products, announces today that its joint venture company, Mansford Biotrace Ltd
has completed the sale of the Biotrace headquarters property for #2.5 million.


The Company announced on 6 April, that contracts had been exchanged for the sale
of the property for #2.5 million with completion expected to take place by the
end of April. Completion has now taken place and the cash consideration
received. As already stated Biotrace will realise a gain of #0.5 million on the
disposal which together with the release of its original investment in the joint
venture will give rise to a cash benefit of #0.6 million for the Group.


                                    - ENDS -





For further information, please contact:

Biotrace International Plc
Ian Johnson, Chief Executive Officer                Tel: +44 (0)1656 641 400
Peter Morgan, Finance Director

Buchanan Communications
Tim Anderson / James Strong                         Tel: +44 (0)20 7466 5000




Notes to editors:

Biotrace International Plc is a leading manufacturer and supplier of industrial
microbiology products. The Company is organised into three business segments:
Food & Environmental, Pharmaceutical, Personal Care & Cosmetics and Defence. The
Group's proprietary technologies are used by most of the world's leading food
and beverage manufacturers who rely on Biotrace products as an essential part of
their quality control procedures. Other industrial customers include
pharmaceutical and personal care product/cosmetics manufacturers together with
environmental/industrial process water clients. The Defence segment provides
systems and consumables for the rapid detection of biological weapons for
military and homeland security organisations.


Formed in 1988 and floated on the London Stock Exchange in 1993, Biotrace had
total revenues of over #29 million in 2005. The Company is headquartered in
Bridgend, UK with manufacturing and sales operations worldwide. Visit Biotrace
at www.biotrace.com



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
DISIMMRTMMTTBAF

Bank Irel13.375 (LSE:BOI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024

Bank Irel13.375 (LSE:BOI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024